(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-0.01%) $82.62
(0.84%) $2.05
(-0.52%) $2 345.50
(-1.05%) $27.37
(-0.32%) $958.40
(0.05%) $0.933
(0.10%) $10.99
(0.00%) $0.796
(1.56%) $93.31
3 days till quarter result
(bmo 2024-05-02)
Expected move: +/- 4.63%
Live Chart Being Loaded With Signals
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit...
Stats | |
---|---|
Dagens volum | 2.99M |
Gjennomsnittsvolum | 3.59M |
Markedsverdi | 20.65B |
EPS | $0 ( 2024-04-25 ) |
Neste inntjeningsdato | ( $0.610 ) 2024-05-02 |
Last Dividend | $0.290 ( 2024-02-29 ) |
Next Dividend | $0 ( N/A ) |
P/E | -270.93 |
ATR14 | $0.0210 (0.05%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-06 | Toth Christopher A. | Buy | 119 076 | Common Stock, $1 par value |
2024-03-06 | Stevens Brian | Buy | 14 289 | Common Stock, $1 par value |
2024-03-06 | Sonig Alok | Buy | 83 353 | Common Stock, $1 par value |
2024-03-06 | Rosenbloom David S. | Buy | 53 584 | Common Stock, $1 par value |
2024-03-06 | Rasul Reazur | Buy | 83 353 | Common Stock, $1 par value |
INSIDER POWER |
---|
77.31 |
Last 100 transactions |
Buy: 1 860 689 | Sell: 191 040 |
Volum Korrelasjon
Baxter International Inc Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
LOCL | 0.91 |
PAK | 0.91 |
RSF | 0.905 |
ZME | 0.905 |
GAZ | 0.903 |
UNG | 0.902 |
GDMA | 0.897 |
UNL | 0.892 |
UBP | 0.889 |
RKLY | 0.889 |
10 Mest negative korrelasjoner | |
---|---|
FSNB | -0.946 |
LHC | -0.934 |
PORT | -0.928 |
ALCC | -0.927 |
HWKZ | -0.92 |
NETC | -0.92 |
EVE | -0.919 |
DSAQ | -0.919 |
JMP | -0.918 |
CLBR | -0.918 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Baxter International Inc Korrelasjon - Valuta/Råvare
Baxter International Inc Økonomi
Annual | 2023 |
Omsetning: | $14.81B |
Bruttogevinst: | $4.98B (33.59 %) |
EPS: | $-0.450 |
FY | 2023 |
Omsetning: | $14.81B |
Bruttogevinst: | $4.98B (33.59 %) |
EPS: | $-0.450 |
FY | 2022 |
Omsetning: | $15.11B |
Bruttogevinst: | $5.40B (35.71 %) |
EPS: | $-4.80 |
FY | 2021 |
Omsetning: | $12.78B |
Bruttogevinst: | $5.11B (39.93 %) |
EPS: | $2.52 |
Financial Reports:
No articles found.
Baxter International Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.290 (N/A) |
$0.290 (N/A) |
$0.290 (N/A) |
$0.290 (N/A) |
$0.290 (N/A) |
$0.290 (N/A) |
$0.290 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0142 | 1982-03-10 |
Last Dividend | $0.290 | 2024-02-29 |
Next Dividend | $0 | N/A |
Payout Date | 2024-04-01 | |
Next Payout Date | N/A | |
# dividends | 150 | -- |
Total Paid Out | $21.30 | -- |
Avg. Dividend % Per Year | 1.37% | -- |
Score | 5.43 | -- |
Div. Sustainability Score | 9.46 | |
Div.Growth Potential Score | 6.41 | |
Div. Directional Score | 7.94 | -- |
Year | Amount | Yield |
---|---|---|
1982 | $0.0568 | 1.35% |
1983 | $0.0692 | 1.21% |
1984 | $0.0808 | 1.41% |
1985 | $0.0908 | 2.80% |
1986 | $0.0988 | 2.59% |
1987 | $0.108 | 2.31% |
1988 | $0.123 | 2.14% |
1989 | $0.138 | 3.17% |
1990 | $0.158 | 2.51% |
1991 | $0.182 | 2.70% |
1992 | $0.217 | 2.25% |
1993 | $0.272 | 3.14% |
1994 | $0.278 | 4.20% |
1995 | $0.301 | 3.94% |
1996 | $1.296 | 11.50% |
1997 | $0.314 | 2.85% |
1998 | $0.315 | 2.32% |
1999 | $0.315 | 1.84% |
2000 | $1.053 | 6.32% |
2001 | $0.316 | 1.30% |
2002 | $0.316 | 1.10% |
2003 | $0.316 | 2.03% |
2004 | $0.316 | 1.93% |
2005 | $0.316 | 1.68% |
2006 | $0.316 | 1.52% |
2007 | $0.392 | 1.55% |
2008 | $0.495 | 1.58% |
2009 | $0.581 | 1.94% |
2010 | $0.642 | 2.03% |
2011 | $0.686 | 2.50% |
2012 | $0.852 | 3.10% |
2013 | $1.042 | 2.84% |
2014 | $1.112 | 2.96% |
2015 | $0.794 | 1.99% |
2016 | $0.505 | 1.36% |
2017 | $0.610 | 1.37% |
2018 | $0.730 | 1.09% |
2019 | $0.850 | 1.30% |
2020 | $0.955 | 1.11% |
2021 | $1.085 | 1.35% |
2022 | $1.150 | 1.32% |
2023 | $1.160 | 2.27% |
2024 | $0.290 | 0.75% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
MTR | Dividend Diamond | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
PDI | Dividend Royal | 2023-11-10 | Monthly | 13 | 7.86% | 8.50 |
ZTR | Dividend King | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
ORC | Dividend Royal | 2023-11-29 | Monthly | 12 | 9.23% | 8.50 |
KIO | Dividend Royal | 2023-12-14 | Monthly | 12 | 7.05% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.178 | 1.500 | 6.45 | 9.67 | [0 - 0.5] |
returnOnAssetsTTM | 0.0939 | 1.200 | 6.87 | 8.24 | [0 - 0.3] |
returnOnEquityTTM | 0.380 | 1.500 | 6.89 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.221 | -1.000 | 7.79 | -7.79 | [0 - 1] |
currentRatioTTM | 1.476 | 0.800 | 7.62 | 6.10 | [1 - 3] |
quickRatioTTM | 0.913 | 0.800 | 9.34 | 7.47 | [0.8 - 2.5] |
cashRatioTTM | 0.491 | 1.500 | 8.38 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.508 | -1.500 | 1.533 | -2.30 | [0 - 0.6] |
interestCoverageTTM | 0.261 | 1.000 | -1.014 | -1.014 | [3 - 30] |
operatingCashFlowPerShareTTM | 3.40 | 2.00 | 8.87 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 2.04 | 2.00 | 8.98 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 1.710 | -1.500 | 3.16 | -4.74 | [0 - 2.5] |
grossProfitMarginTTM | 0.338 | 1.000 | 7.71 | 7.71 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.00863 | 1.000 | -1.827 | -1.827 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.120 | 1.000 | -0.444 | -0.444 | [0.2 - 2] |
assetTurnoverTTM | 0.529 | 0.800 | 9.81 | 7.85 | [0.5 - 2] |
Total Score | 9.46 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 7.66 | 1.000 | 9.33 | 0 | [1 - 100] |
returnOnEquityTTM | 0.380 | 2.50 | 8.00 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 2.04 | 2.00 | 9.32 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.89 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 3.40 | 2.00 | 8.87 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.221 | 1.500 | 7.79 | -7.79 | [0 - 1] |
pegRatioTTM | 0.0187 | 1.500 | -3.21 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.115 | 1.000 | 9.61 | 0 | [0.1 - 0.5] |
Total Score | 6.41 |
Baxter International Inc
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.